Geneva Partners’s Marvell Technology MRVL Stock Holding History

Geneva Partners’s Portfolio MRVL Stock Details MRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-14,390	Closed	-$505K	–	90
2020 Q2	$505K	Buy	+14,390	New	+$421K	0.35%	57

Other funds holding MRVL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Geneva Partners's MRVL Position: Q3 2020 in Review

Geneva Partners sold out of Marvell Technology (MRVL) in Q3 2020, closing a stake of 14,390 shares — an estimated $505K sold.

Geneva Partners first reported a position in MRVL in Q2 2020 and held it in 1 quarter. The position peaked at $505K in Q2 2020. 573 funds tracked by Wall St. Rank hold MRVL as of Q3 2020.

Geneva Partners reported no remaining Marvell Technology position as of Q3 2020 after selling out during the quarter.
Geneva Partners sold 14,390 Marvell Technology shares in Q3 2020, an estimated $505K.
Geneva Partners first reported a position in Marvell Technology in Q2 2020 and held it in 1 quarter.
Geneva Partners's Marvell Technology position peaked at $505K in Q2 2020.
573 funds tracked by Wall St. Rank held Marvell Technology as of Q3 2020.

Based on Geneva Partners's 13F filing for Q3 2020, filed 28 Oct 2020.